Regeneron Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: 114.64

Regeneron Pharmaceuticals, Inc. Interest Coverage Ratio is 114.64 for the Trailing 12 Months (TTM) ending March 31, 2025, a 100.07% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Regeneron Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2024 was 57.30, a -27.05% change year over year.
  • Regeneron Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was 78.55, a -53.80% change year over year.
  • Regeneron Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was 170.02, a 153.42% change year over year.
  • Regeneron Pharmaceuticals, Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was 67.09, a -19.87% change year over year.
Key Data
Date Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA)